| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue | (2,007) | 1,654 | 1,737 | 9,705 | | | Gross Profit | 2,007 | (1,654) | (1,737) | (9,705) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,904 | 1,852 | 1,372 | (767) | | Non Recurring | 3,446 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,343) | (3,506) | (3,109) | (8,938) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (13) | (5) | (2) | 30 | | Earnings Before Interest And Taxes | (3,356) | (3,511) | (3,111) | (8,908) | | Interest Expense | 271 | 264 | 50 |
-
| | Income Before Tax | (3,627) | (3,775) | (3,161) | (8,908) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,627) | (3,775) | (3,161) | (8,908) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,627) | (3,775) | (3,161) | (8,908) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,627) | ($3,775) | ($3,161) | ($8,908) |
|
0.31% Nasdaq 0.00%
Income Statement
